Melt Pharmaceuticals Email Format
Pharmaceutical ManufacturingTennessee, United States2-10 Employees
Melt Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing and commercializing non-intravenous, non-opioid sedation and analgesia medicines for short-duration procedures performed in outpatient and in-office settings. Its product concepts aim to address procedural sedation needs for more than 100 million medical procedures in the United States, offering alternatives that may replace or supplement current sedation approaches. The company operates within the pharmaceutical manufacturing industry and positions itself around first-in-class, needle- and opioid-free formulations intended for rapid onset and short duration use during procedures. Based in Brentwood, Tennessee, Melt Pharmaceuticals is active in developing its MELT-300 and related formulations, with collaboration and development activity noted in its history including partnerships and regulatory-stage work. A recent development includes a collaboration with Catalent for Zydis-based fast-dissolve technology to support its sublingual, non-opioid sedation candidate for procedural use.